Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg have been found in the United States. The FDA ...

“Chronic kidney disease is a global healthcare problem ... GLP-1 agonists – LEADER with liraglutide and SUSTAIN-6 with semaglutide – in which we included important renal endpoints.

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, and growing consumer demand ...

Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial. The Danish ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Ozempic (semaglutide) and Victoza (liraglutide ... and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. Both drugs can be used alone or with certain other diabetes ...

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

A new international clinical trial has shown that the oral form of semaglutide, a medication already known for managing type ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...